Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on May 23, 2024. The filing addresses a corporate governance matter regarding the rescheduling of the company's 2023 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate event notification and contains no financial performance data.
Material Changes
The Board of Directors has rescheduled the 2023 Annual Meeting of Shareholders from July 15, 2024, to August 26, 2024. This change represents an advance of more than 30 days from the anniversary of the 2022 Annual Meeting, triggering specific disclosure requirements under Rule 14a-5(f) of the Exchange Act.
Guidance, Outlook, and Shareholder Actions
Due to the rescheduling of the Annual Meeting, a new deadline has been established for shareholder proposals intended for inclusion in the proxy statement under Rule 14a-8. Proposals must be received by June 21, 2024. The record date, time, and location for the meeting remain as set forth in the previously issued proxy statement.
Key Facts for Investor Verification
- The 2023 Annual Meeting is now scheduled for August 26, 2024.
- The deadline for submitting shareholder proposals for the proxy statement is June 21, 2024.
- Proposals must be delivered to the Corporate Secretary at 1990 Main Street, Suite 750, Sarasota, Florida 34236.
- No financial results or operational updates are included in this specific filing.